10X Capital Management, LLC sold $921K of Galectin Therapeutics (GALT)

Executed Dec 2 2025, disclosed Dec 8 2025, 6 days later, against a two-business-day limit.

Value, as filed

$921K

162,069 sh across 2 lots

Executed

Dec 2 2025

the trade date, as filed

Disclosed

Dec 8 2025

6 days after the trade · past the deadline

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

XL 10X Capital Management, LLC 10% owner profile →

10X Capital Management, LLC (10% owner) filed 4 Form 4 reports as a reporting entity in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Galectin Therapeutics Inc. (GALT). The largest single filing was $921K of GALT (162,069 sh across 2 lots, as filed), executed Dec 2 2025.

The name

GALT

Galectin Therapeutics Inc. GALT · Healthcare · 14 filings in 24 months ticker →

Healthcare · Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic di…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by 10X Capital Management, LLC in GALT

GALTSALE Galectin Therapeutics Inc. $852K
150,000 sh across 2 lots
Exec Dec 2 2025
Filed Dec 4 2025 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. $210K
40,000 sh × $5.25
Exec Nov 11 2025
Filed Nov 12 2025 · 5:30 PM ET GALTSALE Galectin Therapeutics Inc. $148K
30,000 sh × $4.94
Exec Oct 22 2025
Filed Oct 24 2025 · 5:30 PM ET